Raily Aesthetic Medicine International Holdings Ltd. has announced a change in the use of its net proceeds, with plans to reallocate the remaining unutilised funds originally intended for establishing an aesthetic medical hospital in Shanghai City to general working capital. The company cited continued weak market conditions in Shanghai and the absence of a suitable acquisition target as reasons for the adjustment. The Board stated that this reallocation aims to provide greater financial flexibility, ensure sufficient working capital for ongoing operations, and strengthen the company’s ability to respond to future economic uncertainties. The company will continue to assess market conditions and may revise its plans as needed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Raily Aesthetic Medicine International Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260102-11976481), on January 02, 2026, and is solely responsible for the information contained therein.